How private equity affects optometry, Travoprost eluting drug-delivery device shows promise, How to build your practice through social media, and much more available in our digital edition.
Private practice used to be a goal for many ODs interested in managing their own businesses. The rise in private equity in optometry has changed the playing field for ODs looking for an exit strategy as well as those interested in purchasing a practice.
Drug-eluting devices are the future of medication compliance. Learn interim results from the Phase II clinical trial of one such device for controlling IOP in glaucoma patients.
This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.
This email was sent by: %%Member_Busname%% %%Member_Addr%% %%Member_City%%, %%Member_State%%, %%Member_PostalCode%%, %%Member_Country%%
